News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
325,717 Results
Type
Article (24276)
Company Profile (114)
Press Release (301327)
Section
Business (116340)
Career Advice (1067)
Deals (17008)
Drug Delivery (70)
Drug Development (34601)
Employer Resources (148)
FDA (6455)
Job Trends (8065)
News (174304)
Policy (13093)
Tag
Academia (1760)
Africa (475)
Alliances (25307)
Alzheimer's disease (649)
Antibody-drug conjugate (ADC) (44)
Approvals (6405)
Arizona (66)
Artificial intelligence (57)
Asia (20745)
Australia (3644)
Bankruptcy (99)
Best Places to Work (6361)
Biosimilars (42)
Biotechnology (64)
C2C Services and Suppliers (33116)
California (856)
Canada (449)
Cancer (254)
Career advice (917)
Cell therapy (72)
China (89)
Clinical research (26663)
Collaboration (100)
Colorado (34)
COVID-19 (1208)
Cystic fibrosis (33)
Data (160)
Diabetes (53)
Diagnostics (3401)
Diversity, equity & inclusion (40)
Drug pricing (39)
Earnings (47530)
Employer resources (126)
Europe (48193)
Events (47215)
Executive appointments (90)
FDA (6535)
Florida (123)
Funding (64)
Gene therapy (50)
Georgia (36)
GLP-1 (307)
Government (1904)
Healthcare (8444)
Hotbed/Location (219510)
Illinois (101)
Indiana (85)
Infectious disease (1223)
Inflammatory bowel disease (56)
Interviews (154)
IPO (7806)
Job creations (1764)
Job search strategy (829)
Kansas (38)
Layoffs (180)
Legal (2397)
Lung cancer (81)
Management (44)
Manufacturing (54)
Maryland (145)
Massachusetts (636)
Medical device (5900)
Medtech (5904)
Mergers & acquisitions (9193)
Metabolic disorders (151)
Michigan (70)
Minnesota (116)
Neuroscience (729)
New Jersey (294)
New York (286)
NextGen Class of 2024 (3098)
Non-profit (2367)
North Carolina (318)
Northern California (392)
Obesity (101)
Ohio (52)
Opinion (103)
Pennsylvania (196)
People (35432)
Phase I (7509)
Phase II (11248)
Phase III (10060)
Pipeline (57)
Postmarket research (1193)
Preclinical (3702)
Press Release (63)
Rare diseases (59)
Real estate (3337)
Recruiting (56)
Regulatory (9182)
Research institute (1554)
Resumes & cover letters (153)
South America (690)
Southern California (361)
Startups (2303)
Texas (98)
United States (3848)
Vaccines (197)
Washington State (106)
Weight loss (87)
Date
Today (44)
Last 7 days (317)
Last 30 days (942)
Last 365 days (19017)
2024 (13166)
2023 (20585)
2022 (25924)
2021 (28726)
2020 (27006)
2019 (23913)
2018 (17777)
2017 (17568)
2016 (16683)
2015 (19258)
2014 (14075)
2013 (11527)
2012 (12502)
2011 (13061)
2010 (12068)
325,717 Results for "biodelivery sciences international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
OKBio -- Relaunching as Life Science Oklahoma -- to participate in BIO International Convention 2024
Oklahoma’s bioscience community is announcing a relaunch of its industry association, with the new Life Science Oklahoma bringing new leadership, a new format and renewed focus and support to businesses and organizations within the Oklahoma life sciences and healthcare communities.
June 3, 2024
·
4 min read
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Achieve Life Sciences, Inc., a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced publication of the ORCA-V1 trial results in the Journal of the American Medical Association Internal Medicine.
May 6, 2024
·
9 min read
Lone Star Bio
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
Cassava Sciences, Inc. today announced plans to present a virtual oral presentation at the International Conference on Alzheimer’s and Parkison’s Disease (AD/PD 2024) taking place in Lisbon, Portugal from March 5-9, 2024.
March 4, 2024
·
5 min read
BioForest
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
Achieve Life Sciences, Inc. today announced data from the Phase 2 ORCA-V1 vaping cessation trial will be presented today, Friday, May 17, 2024, at the Society of General Internal Medicine (SGIM) Annual Meeting being held in Boston, MA.
May 17, 2024
·
6 min read
Biotech Bay
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion.
June 21, 2024
·
3 min read
BioMidwest
ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announces the issuance of five new patents, including three in Europe and two in China.
May 2, 2024
·
5 min read
Deals
Collegium to Acquire BioDelivery Sciences in an All-Cash Deal
BioDelivery Sciences International, Inc. today announced that it has entered into a definitive merger agreement for Collegium Pharmaceutical, Inc.
February 14, 2022
·
6 min read
Bio NC
BioDelivery Sciences International to Host ELYXYB™ Investor Day
BioDelivery Sciences International, Inc., a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced it will host a virtual ELYXYB™ Investor Day on Thursday, October 14, 2021, at 10:30am ET.
September 30, 2021
·
9 min read
Bio NC
BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), today announced the U.S. commercial launch and availability of ELYXYBTM (celecoxib oral solution), the first and only FDA-approved ready-to-use oral solution for the acute treatment of migraine with or without aura in adults.
February 24, 2022
·
8 min read
Job Trends
9 Life Sciences Companies Hiring in Texas
Looking for a job in Texas? Check out these nine companies hiring life sciences professionals like you.
August 8, 2024
·
1 min read
·
Angela Gabriel
1 of 32,572
Next
